Summit X, LLC
- SEC CIK
- 0001697729
- Latest filing
- Nov 13, 2025
NVO holding history
Novo Nordisk A S in every 13F filed by Summit X, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q3 2025 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −7,034−100.0% | Sold out | Holders |
| Q1 2025 | 7,034 | $488.2K | 0.1% | −687−8.9% | Reduced | Holders |
| Q4 2024 | 7,721 | $663.7K | 0.1% | −321−4.0% | Reduced | Holders |
| Q3 2024 | 8,042 | $1.15M | 0.3% | −1,688−17.3% | Reduced | Holders |
| Q2 2024 | 9,730 | $1.39M | 0.3% | +1,564+19.2% | Added | Holders |
| Q1 2024 | 8,166 | $1.05M | 0.3% | −426−5.0% | Reduced | Holders |
| Q4 2023 | 8,592 | $888.3K | 0.3% | +5,643+191.4% | Added | Holders |
| Q3 2023 | 2,949 | $268.6K | 0.1% | +2,949 | New | Holders |